Long-term outcomes for adult craniopharyngioma following radiation therapy

Acta Oncologica

Volumn 52, Issue 1, 2013, Pages 153-158

  Masson Cote, Laurence ^a   Masucci, Giuseppina Laura ^a   Atenafu, Eshetu G ^b   Millar, Barbara Ann ^a   Cusimano, Michael ^c   Croul, Sidney ^a   Mason, Warren ^a   Laperriere, Normand J ^a   Sahgal, Arjun ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; BRAIN TUMOR; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CATARACT; CAUSE OF DEATH; CAUSE SPECIFIC SURVIVAL; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; CRANIOPHARYNGIOMA; CYST ASPIRATION; CYTOREDUCTIVE SURGERY; DISEASE COURSE; DISEASE SEVERITY; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENINGIOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VISUAL DISORDER; ADJUVANT RADIOTHERAPY; ADULT DISEASE; BRAIN BIOPSY; BRAIN CYST; BRAIN INFARCTION; CONFORMAL RADIOTHERAPY; GROUPS BY AGE; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; RADIATION DOSE FRACTIONATION; SECOND CANCER; STEREOTACTIC TREATMENT; TUMOR GROWTH;

ADULT; AGE FACTORS; AGED; CRANIOPHARYNGIOMA; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; YOUNG ADULT;

EID: 84871401870     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.685525     Document Type: Article

References (13)

1. Sughrue ME, Yang I, Kane AJ, Fang S, Clark AJ, Aranda D, et al. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol 2011; 101:463 - 76.
2. Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D, et al. Craniopharyngioma: A comparison of tumor control with various treatment strategies. Neurosurg Focus 2010;28:E5.
3. Rajan B, Ashley S, Gorman C, Jose CC, Horwich A, Bloom HJ, et al. Craniopharyngioma - a long-term results following limited surgery and radiotherapy. Radiother Oncol 1993;26:1 - 10. (Pubitemid 23063603)
4. Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 2007;82:90 - 5. (Pubitemid 46110912)
5. Regine WF, Mohiuddin M, Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 1993; 27:13 - 21. (Pubitemid 23180136)
6. Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 2002;54:1114 - 20. (Pubitemid 35292623)
7. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, et al. Craniopharyngiomas in children and adults: Systematic analysis of 121 cases with long-term follow- up. Clin Endocrinol (Oxf) 2005;62:397 - 409.
8. Pemberton LS, Dougal M, Magee B, Gattamaneni HR. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol 2005;77:99 - 104. (Pubitemid 41503397)
9. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Neurosurg Focus 1997;3:e1.
10. Jose CC, Rajan B, Ashley S, Marsh H, Brada M. Radiotherapy for the treatment of recurrent craniopharyngioma. Clin Oncol (R Coll Radiol) 1992;4:287 - 9.
11. Rodriguez FJ, Scheithauer BW, Tsunoda S, Kovacs K, Vidal S, Piepgras DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol 2007;31:1020 - 8. (Pubitemid 47012298)
12. Kawamata T, Amano K, Aihara Y, Kubo O, Hori T. Optimal treatment strategy for craniopharyngiomas based on longterm functional outcomes of recent and past treatment modalities. Neurosurg Rev 2010;33:71 - 81.
13. Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 2005;62:197 - 204. (Pubitemid 40203915)